Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Antisense NF-K p65 Oligonucleotide

EU orphan designation number: EU/3/02/106   
Active ingredient: Antisense NF-K p65 Oligonucleotide
Indication: Treatment of active ulcerative colitis
Sponsor: InDex Pharmaceuticals AB
Retzius vg 8, SE-171 77 Stockholm, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/08/2002 Centralised Orphan - Designation EMEA/OD/014/02 (2002)3016 of 30/07/2002
07/12/2011 Other procedure EMEA/OD/014/02
23/10/2012 Other procedure EMEA/OD/014/02